局限性前列腺癌的高度分割放疗方案：GETUG放射肿瘤学组的建议
Highly hypofractionated schedules for localized prostate cancer: Recommendations of the GETUG radiation oncology group.
作者信息
Lapierre Ariane, Hennequin Christophe, Beneux Amandine, Belhomme Sarah, Benziane Ouaritini Nicolas, Biston Marie-Claude, Crehange Gilles, de Crevoisier Renaud, Dumas Jean-Luc, Fawzi Maher, Lisbona Albert, Pasquier David, Pelissier Sandra, Graff-Cailleaud Pierre, Pommier Pascal, Sargos Paul, Simon Jean-Marc, Supiot Stéphane, Tantot Florence, Chapet Olivier
机构信息
Département of de radiothérapie oncologie, centre hospitalier universitaire Lyon Sud, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite, France; Université de Lyon, 69000 Lyon, France.
Department of Radiation Oncology, Hôpital Saint-Louis, 75475 Paris, France.
出版信息
Crit Rev Oncol Hematol. 2022 May;173:103661. doi: 10.1016/j.critrevonc.2022.103661. Epub 2022 Mar 25.
Stereotactic body radiotherapy (SBRT) has become treatment option for localized prostate cancer but the evidence base remains incomplete. Several clinical studies, both prospective and retrospective, have been published. However, treatment techniques, target volumes and dose constraints lack consistency between studies. Based on the current available literature, the French Genito-Urinary Group (GETUG) suggests that.
立体定向体部放疗（SBRT）已成为局限性前列腺癌的治疗选择，但证据基础仍不完整。已经发表了几项前瞻性和回顾性的临床研究。然而，各研究之间的治疗技术、靶区体积和剂量限制缺乏一致性。基于当前可得的文献，法国泌尿生殖组（GETUG）建议如下。
Zotero 插件